v3.26.1
Audited Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Ordinary shares
Subscription receivable
Additional paid-in capital
Retained earnings (Accumulated deficit)
Accumulated other comprehensive income/(loss)
Total attributable to the shareholders of the Company
Non- controlling interests
Total
Balance at Dec. 31, 2022 $ (319,872) $ 1,464,959 $ (591,544) $ 9,570 $ 563,113 $ (462,430) $ 100,683
Balance (in Shares) at Dec. 31, 2022 [1] 167              
Net Profit (loss)       130,193 130,193 (21,775) 108,418
Foreign currency translation adjustment (16,858) (16,858) (5,846) (22,704)
Settlement of Subscription receivable 192,308 192,308 192,308
Issuance of shares 2,866,856 2,866,856 2,866,856
Issuance of shares (in Shares) [1] 2              
Balance at Dec. 31, 2023 (127,564) 4,331,815 (461,351) (7,288) 3,735,612 (490,051) 3,245,561
Balance (in Shares) at Dec. 31, 2023 [1] 169              
Net Profit (loss) (524,643) (524,643) 50,542 (474,101)
Foreign currency translation adjustment 26,163 26,163 6,366 32,529
Reverse Capitalization (6,028,690) (6,028,690) (6,028,690)
Settlement of Subscription receivable 127,564 127,564 127,564
Remeasurement of share based compensation (2,766,856) (2,766,856) (2,766,856)
Issuance of shares under ELOC (204,000) 4,586,236 4,382,236 4,382,236
Issuance of shares under ELOC (in Shares) [1] 211              
Balance at Dec. 31, 2024 (204,000) 122,505 (985,994) 18,875 (1,048,614) (433,143) $ (1,481,757)
Balance (in Shares) at Dec. 31, 2024 380 [1]             380 [2]
Net Profit (loss) 9,879,408 9,879,408 (150,685) $ 9,728,723
Foreign currency translation adjustment (161,946) (161,946) (60,998) (222,944)
Issuance of shares under ELOC 12,620,494 12,620,494 12,620,494
Issuance of shares under ELOC (in Shares) [1] 141,661              
Issuance of shares under conversion 204,000 4,860,427 5,064,427 5,064,427
Issuance of shares under conversion (in Shares) [1] 58,424              
Issuance of shares for business acquisition 257,500 257,500 257,500
Issuance of shares for business acquisition (in Shares) [1] 42              
Issuance of shares for share-based compensation to consultant 20,250 20,250 20,250
Issuance of shares for share-based compensation to consultant (in Shares) [1] 50              
Issuance of shares for warrant exercise
Issuance of shares for warrant exercise (in Shares) [1] 40,065              
Balance at Dec. 31, 2025 $ 17,881,176 $ 8,893,414 $ (143,071) $ 26,631,519 $ (644,826) $ 25,986,693
Balance (in Shares) at Dec. 31, 2025 240,622 [1]             240,622 [2]
[1] The shares as presented have been adjusted retrospectively for Reverse Share Splits effected in February 2025 of 1 share for every 20 existing shares issued, in May 2025 of 1 share for every 10 existing share issued, in August 2025 of 1 share for every 5 shares issued, in December 2025 of 1 share for every 5 shares issued, in January 2026 of 1 share for every 3 shares issued and in March 2026 of 1 share for every 4 shares issued respectively.
[2] The shares as presented have been adjusted retrospectively for Reverse Share Splits effected in February 2025 of 1 share for every 20 existing shares issued, in May 2025 of 1 share for every 10 existing share issued, in August 2025 of 1 share for every 5 shares issued, in December 2025 of 1 share for every 5 shares issued, in January 2026 of 1 share for every 3 shares issued and in March 2026 of 1 share for every 4 shares issued respectively.